Copertina

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yan Han, Yingjie Qiu, Yi Zhao, Isabella Wan, Lang Li, Suyu Liu, Yong Zang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmaceutical Statistics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
di: Yingjie Qiu, et al.
Pubblicazione: (2024)

A Phase I Dose‐Finding Design Incorporating Intra‐Patient Dose Escalation
di: Beibei Guo, et al.
Pubblicazione: (2024)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
di: Gina D'Angelo, et al.
Pubblicazione: (2025)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
di: Tomoyoshi Hatayama, et al.
Pubblicazione: (2025)

A Dose‐Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D‐Optimality
di: Maxine Ajimi, et al.
Pubblicazione: (2026)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
di: Ryo Kitabayashi, et al.
Pubblicazione: (2025)

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
di: Jun Zhang, et al.
Pubblicazione: (2024)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
di: Dario Zocholl, et al.
Pubblicazione: (2025)

Evaluating Safety Rules in Ongoing Dose‐Escalation Trials Using BOIN : A Comparative Analysis of Criteria and Their Impact on Dose‐Level Safety Assessments
di: Stefan Englert, et al.
Pubblicazione: (2026)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
di: Zhiwei Zhang, et al.
Pubblicazione: (2025)

Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk–Benefit Analysis
di: Utkarsh Chauhan, et al.
Pubblicazione: (2025)

A Likelihood Perspective on Dose‐Finding Study Designs in Oncology
di: Zhiwei Zhang
Pubblicazione: (2024)

Reparametrized Firth's Logistic Regressions for Dose‐Finding Study With the Biased‐Coin Design
di: Hyungwoo Kim, et al.
Pubblicazione: (2024)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
di: Konstantinos Sechidis, et al.
Pubblicazione: (2024)

Variable Duration Trial as an Alternative Design for Continuous Endpoints
di: Jitendra Ganju, et al.
Pubblicazione: (2024)

Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
di: Yulia Dyachkova, et al.
Pubblicazione: (2024)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
di: Anders Granholm, et al.
Pubblicazione: (2025)

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
di: Hao Sun, et al.
Pubblicazione: (2024)

To Dilute or Not to Dilute: Nominal Titer Dosing for Genetic Medicines
di: Paul Faya, et al.
Pubblicazione: (2024)

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
di: Yueyang Han, et al.
Pubblicazione: (2025)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
di: Ping Gao, et al.
Pubblicazione: (2025)

A Personalized Dose‐Finding Algorithm Based on Adaptive Gaussian Process Regression
di: Yeonhee Park, et al.
Pubblicazione: (2024)

A Tree‐Based Scan Statistic for Detecting Signals of Drug–Drug Interactions in Spontaneous Reporting Databases
di: Seok‐Jae Heo, et al.
Pubblicazione: (2025)

Pre‐Posterior Distributions in Drug Development and Their Properties
di: Andrew P. Grieve
Pubblicazione: (2024)

Applying the Estimand Framework to Non‐Inferiority Trials
di: Helle Lynggaard, et al.
Pubblicazione: (2024)

Principles for Defining Estimands in Clinical Trials—A Proposal
di: Tobias Mütze, et al.
Pubblicazione: (2024)

Detection of Outlying Correlation Coefficients in Multicenter Clinical Trials
di: Lieven Desmet, et al.
Pubblicazione: (2025)

Statistical Consideration for Event‐Free Survival With Cure Rate in Acute Myeloid Leukemia Studies
di: Yuichiro Kaneko, et al.
Pubblicazione: (2025)

Survival Analysis Without Sharing of Individual Patient Data by Using a Gaussian Copula
di: Federico Bonofiglio
Pubblicazione: (2024)

A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design
di: Qingyang Zhang, et al.
Pubblicazione: (2025)

A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls
di: Manoj Khanal, et al.
Pubblicazione: (2025)

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
di: Jerome Sepin, et al.
Pubblicazione: (2025)

“Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation
di: Emilie Højbjerre‐Frandsen, et al.
Pubblicazione: (2026)

An Adaptive Three‐Arm Comparative Clinical Endpoint Bioequivalence Study Design With Unblinded Sample Size Re‐Estimation and Optimized Allocation Ratio
di: David Hinds, et al.
Pubblicazione: (2024)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
di: Vahan Aslanyan, et al.
Pubblicazione: (2024)

Mediation Analysis of Path‐Specific Effects in Randomised Clinical Trials With Repeatedly Measured Mediators and Outcomes
di: Martin Linder, et al.
Pubblicazione: (2025)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
di: Go Horiguchi, et al.
Pubblicazione: (2026)

A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval‐Bounded Longitudinal Measurements and Survival Times With Cure Proportion
di: Zhanfeng Wang, et al.
Pubblicazione: (2026)

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment
di: Jixian Wang, et al.
Pubblicazione: (2025)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
di: Chiara Micoli, et al.
Pubblicazione: (2025)